This thread is directed to all of you searching for plasma donors and/or amplifying requests for plasma donation, but most importantly, for physicians suggesting plasma donation, or patients’ families demanding #ConvalescentPlasma treatment for their loved ones.
Over the past year and more, we have had #ConvalescentPlasma dominating conversations about #COVID_19 treatment. Families have run from pillar to post trying to find a compatible donor. We’ve had celebrities urging people to donate.
Importantly, we’ve had heartbroken families feel guilty about not having been able to identify a suitable donor in time to save their loved one’s life. This thread is meant for all of them.
Why did people think #ConvalescentPlasma will help? It is based on the theory that patients who get infected with #SARSCov2 develop antibodies to the infection, which will protect them for some time from getting reinfected.
And that these antibodies, if transfused to someone who has active #COVID_19 will fight the infection using these antibodies. Theoretically, it makes a lot of sense.
But that’s not how we evaluate new treatments. For any new treatment to be proven to be better than the existing standard of care, we need to show in a randomized controlled trial (RCT) that it is indeed superior. This is the gold standard for any new intervention to be evaluated
What do the RCTs conclude about #ConvalescentPlasma for #COVID_19? There were 10 trials, of which 3 were from India! Important that the second largest trial (464 patients) came from India, the PLACID trial by @ICMRDelhi. The largest was #RECOVERY (10406 patients) from the UK NHS
The PLACID trial, was in fact, the first large trial to be reported.
PLACID showed no improvement with #ConvalescentPlasma with respect to its composite primary outcome of all cause mortality and progression to severe disease. Neither did it show any difference with biomarkers of severity of disease, or in neutralizing antibody titres
A meta analysis of the 10 RCTs was performed. This too did not show any difference between #ConvalescentPlasma and standard of care. However, physicians kept promoting, patients’ families kept demanding…
Thousands of patients families scoured around trying to find donors. Social media was rife with requests and pleas for #ConvalescentPlasma donations. Celebrities made fervent pleas to their followers and urged them to donate
We now have the results of the #RECOVERY trial – by far the largest trial ever done for #COVID_19 treatment. A phenomenal effort from the @NHSuk , @PeterHorby, @MartinLandray and colleagues
#RECOVERY recruited more than 11500 patients and compared between #ConvalescentPlasma and standard of care. Again, there was no difference in mortality. Basically, what this meant was that #ConvalescentPlasma DOES NOT WORK in #COVID_19
Not only in the whole set of patients, #ConvalescentPlasma did not work in ANY subset of patients.
And an updated meta analysis of 12 randomized trials confirms that #ConvalescentPlasma does not improve any mortality from #COVID_19
We have to let science decide our treatment policy. Not personal opinions, eminence, or experience. And based on very good science, we now know that #ConvalescentPlasma is not useful in #COVID_19
I repeat. #ConvalescentPlasma is not useful for the treatment of #COVID_19. The end.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Pramesh CS

Pramesh CS Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @cspramesh

13 May
Today, our usual "Thursday morning meeting" at @TataMemorial was anything other than usual...
0.4%. This number becomes significant in the last tweet of this thread.
Follow on.
The topic for today's meeting was "How have nurses contributed to the @TataMemorial #COVID_19 response? This was planned to coincide with the #InternationalNursesDay2021 and the #InternationalNursesWeek
Our very unassuming Deputy Nursing Superintendent made the presentation. For the next 25 minutes, the audience was spellbound. She described how the nurses helped @TataMemorial handle the pandemic over the past 15 months.
Read 12 tweets
18 Apr
I know the #COVID-19 numbers in India are not looking good, but here are my (not so) random thoughts on it Image
We have 2 options – one, rant & rail against the ‘system’ and lament how it has let us down; second, do whatever we can to avoid getting infected & if infected, minimize adverse consequences to ourselves & others. If you belong to the first, you can stop reading now
How can we avoid getting infected? There’s no magic bullet, I’m afraid. This is primarily a “stick to the basics” approach. More difficult than it sounds.
Read 25 tweets
8 Apr
Why is there a shortage of Remdesivir, with family members desperately trying to procure it when it has been proven that it is no better than routine care? #EvidenceBasedMedicine
There are two living meta analysis and systematic reviews that show it is not better than routine care. Close to 4000 patients in randomized trials showing no benefit, and patients & families desperate and buying in the black market because they believe it will save their patient
Wow! This tweet seems to have stirred up a lot of interest (and violent reactions). I'm glad there has been (some) discussion about the science, and the evidence, and justifiable disagreement. We've had experienced experts in the field weighing in, and I respect those views
Read 19 tweets
27 Feb
Let me tell you an amazing story...
In the 1990s, a maverick breast surgeon at @TataMemorial (fresh from his return from the UK) stepped up to do research. Now, to understand the situation, you should go back 30 years, when research was not as big as it is now, and certainly not from surgeons.
Surgeons, and especially cancer surgeons, were renowned for their technical prowess, and their sheer bravado – "wherever the cancer, however advanced, I will take it out". So, our surgeon-researcher was ridiculed for even attempting clinical research
Read 18 tweets
29 Jan
Great work by Connor Wells & Shubham Sharma @QueensUHealth asking two important #GlobalHealth questions
1. Is there a #publicationbias against papers from #LMICs?
2. Do oncology RCTs match the global disease burden?
Confirms something we always knew
What we did was this...
We identified 3 problems and 2 facts
We looked at all phase 3 studies in oncology from 2014 to 2017; classified origin of these RCTs based on #WorldBank economic classification of countries. We compared RCT designs and results from HICs and LMICs. The findings were striking…
Of 694 RCTs, 636(92%) were led by HICs; 58(8%) by LMICs. This is the first problem – huge imbalance in where research is done. Cancer incidence is strikingly different in HICs & LMICs, with considerable burden in LMICs. How can we accept such a skewed distribution of research?
Read 10 tweets
25 Dec 20
The WHO’s chief scientist on a year of loss and learning nature.com/articles/d4158…
For anyone remotely involved in healthcare, these are life lessons from @doctorsoumya. A must read.
For those of you who want a quick analysis, thread.
Disclaimer: I’m just breaking this up & annotating them with my own comments. Between quotes are her exact words (with some poetic license)
Planning ahead & prioritizing first steps – an important aspect of taking up a new job
“My original plan for 2020 included rolling out new processes to ensure the quality of technical documents, such as guidelines on water quality, tobacco advertising and immunization programmes”
Read 23 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(